Vitrac Therapeutics, LLC
1 clinical trials · Sponsor
◉ Watch Vitrac Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer (NCT05374538) | Vitrac Therapeutics, LLC | 2022-11-09 |
Track Vitrac Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.